Physician profile
Peter Papagiannopoulos
NPI 1750729018
$3,210.88
in general payments reported to CMS, 2019-2025
9 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $51.20 · 2021: $101 · 2022: $752 · 2023: $448 · 2024: $972 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $1,135.04 | 2019-2023 | Trudi Nav Cable |
| Medtronic, INC. | $533.21 | 2023-2025 | Stealthstation S8 Platform, Propel |
| Aerin Medical INC. | $375.39 | 2020-2024 | |
| Stryker Corporation | $348.32 | 2023-2024 | Scopis Ent, N/A |
| Integra Lifesciences Corporation | $332.02 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Neurent Medical Limited | $151.26 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Intersect Ent, INC. | $141.28 | 2019-2020 | |
| Optinose US, INC. | $101.34 | 2021 | |
| Cook Medical LLC | $93.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Papagiannopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.